The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk

https://doi.org/10.1016/j.csbj.2021.01.039Get rights and content
Under a Creative Commons license
open access

Highlights

  • Conjunctivitis was a rare and self-limited complication in adults with COVID-19.

  • The coronavirus receptors varied in infants’ and adults’ conjunctiva-cornea tissues.

  • The coronavirus receptors expressed in mice lacrimal glands.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which induced mainly the respiratory damage also caused ocular surface symptoms. However, the detailed description of ocular manifestations, severity fluctuations in confirmed COVID-19 adult patients still lacked. We analyzed onset clinical symptoms and duration, ocular symptoms, needs for medication, outcomes in 28 conjunctivitis patients who were extracted from 3198 COVID-19 patients hospitalized in Huoshenshan Hospital and Taikangtongji Hospital, Wuhan, China. The expression levels of ACE2, TMPRSS2, ANPEP, DPP4, NRP1 on fetal and adult ocular surface and mouse lacrimal glands were assessed by single cell seq analysis. Our results indicated that conjunctivitis was a rare and self-limited complication in adults with COVID-19 while the existence of coronavirus receptors on human ocular surface and mouse lacrimal glands indicated the risk of SARS-CoV-2 infection. Our research firstly examined SARS-CoV-2 receptors, including the new discovered one, NRP1, on the fetal ocular surface and in the mouse lacrimal glands.

Keywords

COVID-19
SARS-CoV-2
Ocular infection

Cited by (0)

1

Contributed equally to this article.